Cargando…
Cell facilitation promotes growth and survival under drug pressure in breast cancer
The interplay of positive and negative interactions between drug-sensitive and resistant cells influences the effectiveness of treatment in heterogeneous cancer cell populations. Here, we study interactions between estrogen receptor-positive breast cancer cell lineages that are sensitive and resista...
Autores principales: | Emond, Rena, Griffiths, Jason I., Grolmusz, Vince Kornél, Nath, Aritro, Chen, Jinfeng, Medina, Eric F., Sousa, Rachel S., Synold, Timothy, Adler, Frederick R., Bild, Andrea H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310817/ https://www.ncbi.nlm.nih.gov/pubmed/37386030 http://dx.doi.org/10.1038/s41467-023-39242-6 |
Ejemplares similares
-
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model
por: Grolmusz, Vince Kornél, et al.
Publicado: (2020) -
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
por: Farmaki, Elena, et al.
Publicado: (2023) -
A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types
por: Bishara, Isaac, et al.
Publicado: (2022) -
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022) -
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning
por: Nath, Aritro, et al.
Publicado: (2022)